SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039975
Filing Date
2023-08-09
Accepted
2023-08-08 17:36:51
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acor-20230630.htm   iXBRL 10-Q 2248916
2 EX-31.1 acor-ex31_1.htm EX-31.1 14070
3 EX-31.2 acor-ex31_2.htm EX-31.2 12875
4 EX-32.1 acor-ex32_1.htm EX-32.1 8145
5 EX-32.2 acor-ex32_2.htm EX-32.2 8239
  Complete submission text file 0000950170-23-039975.txt   9791845

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acor-20230630.xsd EX-101.SCH 64147
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acor-20230630_cal.xml EX-101.CAL 55312
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acor-20230630_pre.xml EX-101.PRE 405944
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acor-20230630_def.xml EX-101.DEF 251154
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acor-20230630_lab.xml EX-101.LAB 552161
68 EXTRACTED XBRL INSTANCE DOCUMENT acor-20230630_htm.xml XML 2015036
Mailing Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965
Business Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965 914-347-4300
Acorda Therapeutics, Inc. (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 133831168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 231152720
SIC: 2836 Biological Products, (No Diagnostic Substances)